Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine® CX516 in elderly participants with mild cognitive impairment

A progress report

Verfasser / Beitragende:
[Steven Johnson, Vincent Simmon]
Ort, Verlag, Jahr:
2002
Enthalten in:
Journal of Molecular Neuroscience, 19/1-2(2002-08-01), 197-200
Format:
Artikel (online)
ID: 471160245